Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 23/09/2011
PIL Prempak-C

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 25/08/2011 and displayed until 23/09/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 14/03/2011 and displayed until 25/08/2011
Reasons for adding or updating:
  • Change of contra-indications
Updated on 17/08/2010 and displayed until 14/03/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 15/07/2010 and displayed until 17/08/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 31/03/2010 and displayed until 15/07/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 29/05/2009 and displayed until 31/03/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 22/08/2008 and displayed until 29/05/2009
Reasons for adding or updating:
  • Change to instructions about overdose
Updated on 06/06/2008 and displayed until 22/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/09/2007 and displayed until 06/06/2008
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change of inactive ingredient
  • Change to date of revision
Updated on 10/02/2006 and displayed until 14/09/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to how the medicine works
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 27/06/2005 and displayed until 10/02/2006
Reasons for adding or updating:
  • Change to storage instructions
  • Change from BAN to rINN
  • Change to date of revision
Updated on 20/02/2004 and displayed until 27/06/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 30/09/2003 and displayed until 20/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 08/07/2002 and displayed until 30/09/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   norgestrel
   oestrogens, conjugated